Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BeneFIX Prophylaxis vs On-Demand in Severe Hemophilia B
NCT00364182Phase 3Completed
- Sponsor
- Pfizer
- Start
- May 2007
- Primary completion
- Oct 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 9
01
Overview
A Phase 3 trial of coagulation factor ix recombinant in hemophilia B (HB), sponsored by Pfizer. Started May 2007; status: completed.
02
Drugs
coagulation factor ix recombinant
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on NCT00364182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00364182.